Cargando…

Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression

The present study aimed to investigate the effects of 17β-estradiol and tamoxifen, an agonist and inhibitor of the estrogen receptor (ER), respectively, on the proliferation and apoptosis of gastric cancer cells, as well as the messenger (m)RNA expression levels of ER-α36. Nested reverse transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuming, Chen, Qiuyue, Huang, Xuan, Zou, Feng, Fu, Zhengqi, Chen, Ying, Li, Yan, Wang, Zhaoyi, Liu, Lijiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244966/ https://www.ncbi.nlm.nih.gov/pubmed/28123522 http://dx.doi.org/10.3892/ol.2016.5424

Ejemplares similares

ER-α36-mediated gastric cancer cell proliferation via the c-Src pathway
por: WANG, XUMING, et al.
Publicado: (2013)

Involvement of the Akt signaling pathway in ER-α36/GRP94-mediated signaling in gastric cancer
por: FU, ZHENGQI, et al.
Publicado: (2014)

Fas expression is downregulated in gastric cancer
por: Wang, Xuming, et al.
Publicado: (2017)

Estrogen receptor variant ER‐α36 promotes tamoxifen agonist activity in glioblastoma cells
por: Qu, Chao, et al.
Publicado: (2019)

Tamoxifen enhances stemness and promotes metastasis of ERα36(+) breast cancer by upregulating ALDH1A1 in cancer cells
por: Wang, Qiang, et al.
Publicado: (2018)

CD36 plays a critical role in proliferation, migration and tamoxifen-inhibited growth of ER-positive breast cancer cells
por: Liang, Yu, et al.
Publicado: (2018)

Estrogen Receptor (ER)-α36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models
por: Zou, Wei, et al.
Publicado: (2015)

Enhancement of Sensitivity to Tamoxifen by Berberine in Breast Cancer Cells by Inhibiting ER-α36 Expression
por: Pan, Xiaohua, et al.
Publicado: (2022)

Effect of 17β-Estradiol, Progesterone, and Tamoxifen on Neurons Infected with Toxoplasma gondii In Vitro
por: Galván Ramírez, María de la Luz, et al.
Publicado: (2021)

Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
por: Yin, Li, et al.
Publicado: (2014)

Effects of 17β-Estradiol and Estrogen Receptor Antagonists on the Proliferation of Gastric Cancer Cell Lines
por: Kim, Myung-Jin, et al.
Publicado: (2013)

Estrogen Receptor-α36 Is Involved in Pterostilbene-Induced Apoptosis and Anti-Proliferation in In Vitro and In Vivo Breast Cancer
por: Pan, Chi, et al.
Publicado: (2014)

Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells
por: Qi, Wenwen, et al.
Publicado: (2016)

17-β Estradiol up-regulates energy metabolic pathways, cellular proliferation and tumor invasiveness in ER+ breast cancer spheroids
por: Pacheco-Velázquez, Silvia Cecilia, et al.
Publicado: (2022)

Protein arginine N-methyltransferase 2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-α36
por: Shen, Yingying, et al.
Publicado: (2018)

Estradiol and progesterone regulate proliferation and apoptosis in colon cancer
por: Sasso, Corina Verónica, et al.
Publicado: (2019)

17β-estradiol promotes acute refeeding in hungry mice via membrane-initiated ERα signaling
por: Yu, Kaifan, et al.
Publicado: (2020)

Dynamin II is required for 17β-estradiol signaling and autophagy-based ERα degradation
por: Totta, Pierangela, et al.
Publicado: (2016)

Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
por: Mondal, Samim Ali, et al.
Publicado: (2023)

Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
por: Mondal, Samim Ali, et al.
Publicado: (2023)

ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
por: Lin, Sheng-Li, et al.
Publicado: (2010)

Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes
por: Rondón-Lagos, Milena, et al.
Publicado: (2016)

Tamoxifen Action in ER-Negative Breast Cancer
por: Manna, Subrata, et al.
Publicado: (2016)

Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation
por: Severson, Tesa M., et al.
Publicado: (2016)

Modulation of transforming growth factor beta expression and induction of apoptosis by tamoxifen in ER positive and ER negative breast cancer cells.
por: Benson, J. R., et al.
Publicado: (1996)

Estrogen protects SGC7901 cells from endoplasmic reticulum stress-induced apoptosis by the Akt pathway
por: FU, ZHENGQI, et al.
Publicado: (2014)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
por: Liu, Ying, et al.
Publicado: (2020)

Combined effects of 17β-estradiol and exercise training on cardiac apoptosis in ovariectomized rats
por: Lin, Yi-Yuan, et al.
Publicado: (2018)

Troglitazone-Induced PRODH/POX-Dependent Apoptosis Occurs in the Absence of Estradiol or ERβ in ER-Negative Breast Cancer Cells
por: Lewoniewska, Sylwia, et al.
Publicado: (2021)

Effect of silk fibroin scaffold loaded with 17-β estradiol on the proliferation and differentiation of BMSCs
por: Bai, Juan, et al.
Publicado: (2023)

Effects of 17-α ethynyl estradiol on proliferation, differentiation & mineralization of osteoprecursor cells
por: Park, Jun-Beom
Publicado: (2012)

Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells
por: Castracani, Carlo Castruccio, et al.
Publicado: (2020)

Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells
por: Kim, Seung-Su, et al.
Publicado: (2020)

In vitro inhibition of porcine cytochrome P450 by 17β -estradiol and 17α-estradiol
por: Zamaratskaia, Galia, et al.
Publicado: (2011)

Tamoxifen-Independent Recombination in the RIP-CreER Mouse
por: Liu, Yanmei, et al.
Publicado: (2010)

Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis
por: Esserman, Laura J, et al.
Publicado: (2005)

Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1
por: Wang, Wen-zhong, et al.
Publicado: (2010)

ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway
por: Li, Guangliang, et al.
Publicado: (2020)

Low Dose of Apelin-36 Attenuates ER Stress-Associated Apoptosis in Rats with Ischemic Stroke
por: Qiu, Jian, et al.
Publicado: (2017)

Estradiol and Tamoxifen Induce Cell Migration through GPR30 and Activation of Focal Adhesion Kinase (FAK) in Endometrial Cancers with Low or without Nuclear Estrogen Receptor α (ERα)
por: Tsai, Chia-Lung, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jbc8liql7fpekal8bjddj5eph3